VAeX Capital Partners

VAeX focuses on Seed and early Start-up rounds, typically providing first or second institutional capital to European technology companies. The firm targets technically differentiated businesses at their formative stages, supporting product development, team building, and initial go-to-market execution. VAeX's concentrated portfolio approach means each investment receives significant attention and active partnership.

VAeX invests across Europe with a primary emphasis on France, Germany, the Nordics, and the United Kingdom. While the firm is headquartered in Paris, its investment mandate is pan-European, targeting the continent's leading technology ecosystems. VAeX leverages its proximity to the Paris-Saclay innovation cluster and Station F for deal origination across these markets.

VAeX is a generalist-agnostic investor, pursuing exceptional founding teams across enterprise software, artificial intelligence and machine learning, fintech, digital health, climate technology, and industrial technology. The firm deliberately avoids sector specialization, preferring to follow founder vision and technical differentiation rather than predetermined vertical mandates. This approach allows VAeX to capture opportunities that span traditional category boundaries.

VAeX sources investment opportunities through deep embeddedness in the European technology ecosystem, particularly leveraging relationships within the French entrepreneurial community and the broader Paris-Saclay innovation cluster. The firm relies on proprietary networks, repeat founder relationships, and thesis-driven origination rather than auction processes. VAeX's concentrated approach favors relationship-based, competitive-edge sourcing over high-volume deal funnels.

No. VAeX does not publicly disclose assets under management, aggregate deployment figures, or fund-level performance data. This discretion is consistent with its early-stage, conviction-driven investment posture and reflects the firm's preference for operating outside the capital-raising narrative common among larger venture platforms. Institutional allocators should contact the firm directly for detailed quantitative disclosure.